Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma
Current methodologies for developing PDX in humanized mice in preclinical trials with immune-based therapies are limited by GVHD. Here, we compared two approaches for establishing PDX tumors in humanized mice: (1) PDX are first established in immune-deficient mice; or (2) PDX are initially establish...
Main Authors: | Chi Yan, Caroline A. Nebhan, Nabil Saleh, Rebecca Shattuck-Brandt, Sheau-Chiann Chen, Gregory D. Ayers, Vivian Weiss, Ann Richmond, Anna E. Vilgelm |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/14/3695 |
Similar Items
-
Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma
by: Takahito Sugase, et al.
Published: (2020-05-01) -
Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis
by: Ken Kageyama, et al.
Published: (2017-06-01) -
An Orthotopic Model of Uveal Melanoma in Zebrafish Embryo: A Novel Platform for Drug Evaluation
by: Chiara Tobia, et al.
Published: (2021-12-01) -
Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade
by: Chi Yan, et al.
Published: (2021-06-01) -
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
by: Jie Yin, et al.
Published: (2023-04-01)